Skip to main content
. Author manuscript; available in PMC: 2011 Mar 16.
Published in final edited form as: Oncogene. 2010 Jun 21;29(37):5159–5170. doi: 10.1038/onc.2010.255

Table 1.

Promoter methylation of CXCL family genes in lung cancer

No. Gene CpG island property
Methylated (%)
Array** positive (#)
CpG* (#) Size (bp) GC (%) Obs/exp Cell lines NHBEC PBMC
1 CXCL1 54 626 69.3 0.74 0 - - 0
2 CXCL2 62 623 69.2 0.84 0 - - 1
3 CXCL3 62 636 69.0 0.84 0 - - 1
4 CXCL4 (PF4) 22 302 65.6 0.68 82 90 100 2
5 CXCL5 26 216 70.8 0.69 65 0 15 3
6 CXCL6 23 207 73.4 0.85 65 0 55 1
7 CXCL7 (PPBP) 0 - - - - - - 0
8 CXCL8 (IL-8) 0 - - - - - - 1
9 CXCL9 0 - - - - - - 0
10 CXCL10 0 - - - - - - 1
11 CXCL11 0 - - - - - - 3
12 CXCL12 223 2677 60.9 0.90 63 0 0 1
13 CXCL13 0 - - - - - - 0
14 CXCL14 82 803 68.0 0.90 59 5 10 2
15 CXCL16 134 1372 69.2 0.82 0 - - 1
16 CXCL17 0 - - - - - - 0
*

When a gene has no CpG island the CpG number was shown as 0.

**

Array positive indicates the number of lung adenocarcinoma cell lines (out of 6 cell lines) that after DAC treatment showed a 2-fold or higher increase in expression.